Okasa Pharma Profile
Key Indicators
- Authorised Capital ₹ 10.50 Cr
- Paid Up Capital ₹ 2.20 M
- Company Age 34 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 5.25 Cr
- Revenue Growth -83.99%
- Profit Growth 93.57%
- Ebitda -5.20%
- Net Worth -0.20%
- Total Assets -0.20%
About Okasa Pharma
Okasa Pharma Private Limited (OPPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 May 1990 and has a history of 34 years and nine months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Metals And Minerals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.50 Cr and a paid-up capital of Rs 2.20 M.
The company has closed loans amounting to ₹5.25 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Raman Athipotta and Srinivas Hariharan serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239MH1990PTC071153
- Company No.
071153
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 May 1990
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Okasa Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raman Athipotta  | Director | 31-Jan-2015 | Current |
| Srinivas Hariharan | Director | 04-Sep-2002 | Current |
Financial Performance of Okasa Pharma.
Okasa Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 83.99% decrease. The company also saw a substantial improvement in profitability, with a 93.57% increase in profit. The company's net worth dipped by a decrease of 0.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Okasa Pharma?
In 2023, Okasa Pharma had a public holding of 13.10%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Alps Remedies Private LimitedRaman Athipotta is a mutual person
- Orion Life Sciences Llp
Srinivas Hariharan is a mutual person
- Dna Pharma Llp
Srinivas Hariharan is a mutual person
- Advanced Remedies Llp
Srinivas Hariharan is a mutual person
- One World Pharma Llp
Srinivas Hariharan is a mutual person
- Healingcross Pharma Private Limited
Srinivas Hariharan is a mutual person
Charges (Loans)
₹0
₹5.25 Cr
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 3.75 Cr
- The Saraswat Co Operative Bank Ltd : 1.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Nov 2004 | Axis Bank Limited | ₹3.75 Cr | Satisfied |
| 04 Jan 1993 | The Saraswat Co Operative Bank Ltd | ₹1.50 Cr | Satisfied |
How Many Employees Work at Okasa Pharma?
Okasa Pharma has a workforce of 1 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Okasa Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Okasa Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
.webp){kind=small}
